Treating coronavirus patients with the antiviral drug remdesivir showed no “significant clinical benefits” in the first randomised trial of its
Read more
Home » remdesivir »
remdesivir
Remdesivir shows success in large COVID-19 trial. Will become ‘new standard of care,’ Fauci says.
The drug remdesivir significantly reduces the time it takes for COVID-19 patients to recover, as compared with a placebo treatment,
Read more
Antiviral remdesivir prevents disease progression in monkeys with COVID-19
Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques
Read more